Navigation Links
Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
Date:8/10/2010

Two NJIT biomedical researchers have received the prestigious Coulter Foundation Translational Awards for promising patent applications that may some day extend peoples' lives.

The Coulter program provides funding for professors in established biomedical engineering departments within the U.S. Initial funding for each professor will be at least $200,000 over a two-year period.

NJIT Associate Professor Treena Arinzeh will receive funding for her patent application to create an electro-spun composite material for bone repair applications. Her composite material can be combined with stem cells to enhance the rate of bone repair.

NJIT Assistant Professor Cheul Cho will receive support for his patent application for an extracorporeal bio-artificial liver assist device with human stem cell-derived hepatocytes for the treatment of liver failure. His project aims to differentiate human embryonic stem (ES) cells into functional hepatocytes and to evaluate their therapeutic efficacy in a bio-artificial liver (BAL) for the treatment of acute liver failure. Current potential cell-based therapies and extracorporeal BAL devices for the treatment of liver failure are severely limited by the low availability of functional human liver cells, called hepatocytes.

Arinzeh's research focuses on tissue engineering, the application of principles and methods of engineering and life sciences toward a fundamental understanding and development of biological substitutes to restore, maintain and improve human tissue functions. Bone regeneration may be achieved by the use of osteogenic cells and/or factors to induce bone growth in combination with an appropriate scaffold to guide and support the laying down of new bone tissue.

Optimally, a scaffold for bone tissue engineering should satisfy the following minimum requirements, she said. It must be biocompatible, able to coexist with living tissues or organisms without causing harm. It must have osteoconductivity, able to serve as a scaffold or matrix on which bone cells may attach, migrate and form new bone. It should have minute openings, pores or holes, so that bone can grow inside the material. It should be biodegradable, able to break down in the body without causing harm. And, it should have mechanical integritythe ability to hold together and withstand chemical, physical, and biological forces.

Cho's research focuses on designing a clinically-scaled bio-artificial liver. Approximately 10 percent of the liver mass is necessary to support a patient with acute liver failure, which is a critical limitation for many cell-based therapies for liver failure.

Embryonic stem cells are considered a potential source of cells for hepatic therapies due to their limitless capacity for self-renewal and proliferation, and their ability to differentiate into all major cell lineages.

Cho's novel method differentiates embryonic stem cells into hepatocytes with high purity. Incorporating these cell-derived hepatocytes into a device to treat fulminant hepatic failure has improved animal survival, thereby underscoring the cells' therapeutic potential. (A provisional patent was also filed for this project.)


'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert  

Related biology news :

1. Landmark study unlocks stem cell, DNA secrets to speed therapies
2. Artificial bee eye gives insight into insects visual world
3. Artificially controlling water condensation leads to room-temperature ice
4. Artificial butterfly in flight and filmed
5. Scientists create artificial human skin with biomechanical properties using tissue engineering
6. New studies help establish potential of artificial liver support devices
7. Artificial light at night disrupts cell division
8. Early artificial pancreas trials show benefits for kids, teenagers with diabetes overnight
9. Artificial muscles restore ability to blink, save eyesight
10. ESHRE announces its campus workshop: Artificial Insemination: An Update
11. Oscar Pistorius artificial limbs give him clear, major advantage for sprint running
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem cell, artificial liver research receives Coulter Foundation funding at NJIT
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology: